Sio Gene Therapies Inc

NASDAQ:SIOX   10:16:25 AM EDT
2.70
-0.03 (-1.10%)
Other Pre-Announcement

Sio Gene Therapies Announces Fiscal Year 2020 Year-End Financial Results And Expected Fiscal Year 2021 Key Milestones

Published: 06/09/2021 11:54 GMT
Sio Gene Therapies Inc (SIOX) - Sio Gene Therapies Announces Fiscal Year 2020 Year-end Financial Results and Expected Fiscal Year 2021 Key Milestones.
Q4 Loss per Share $0.05.
Q4 Earnings per Share Estimate $-0.17 -- Refinitiv Ibes Data (analyst estimates).
Sio Gene Therapies - As of March 31, 2021, Had $119.0 Million of Cash, Cash Equivalents.
Sio Gene Therapies - Estimate That Current Cash, Cash Equivalents Will Sustain Operations Into Q4 2022.